Bernd R. Seizinger - 18 May 2022 Form 4 Insider Report for Aprea Therapeutics, Inc. (APRE)

Role
Director
Signature
/s/ Scott M. Coiante, attorney-in-fact
Issuer symbol
APRE
Transactions as of
18 May 2022
Net transactions value
+$35,500
Form type
4
Filing time
19 May 2022, 16:31:21 UTC
Previous filing
01 Jul 2021
Next filing
01 Aug 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APRE Common Stock Purchase $35,500 +50,000 +19% $0.7100* 318,580 18 May 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.